These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 30560106)
1. Application of Small Epigenetic Modulators in Pediatric Medulloblastoma. Zwergel C; Romanelli A; Stazi G; Besharat ZM; Catanzaro G; Tafani M; Valente S; Mai A Front Pediatr; 2018; 6():370. PubMed ID: 30560106 [TBL] [Abstract][Full Text] [Related]
2. Pharmacologic Targeting of Chromatin Modulators As Therapeutics of Acute Myeloid Leukemia. Lu R; Wang GG Front Oncol; 2017; 7():241. PubMed ID: 29075615 [TBL] [Abstract][Full Text] [Related]
4. Small molecule epigenetic screen identifies novel EZH2 and HDAC inhibitors that target glioblastoma brain tumor-initiating cells. Grinshtein N; Rioseco CC; Marcellus R; Uehling D; Aman A; Lun X; Muto O; Podmore L; Lever J; Shen Y; Blough MD; Cairncross GJ; Robbins SM; Jones SJ; Marra MA; Al-Awar R; Senger DL; Kaplan DR Oncotarget; 2016 Sep; 7(37):59360-59376. PubMed ID: 27449082 [TBL] [Abstract][Full Text] [Related]
5. Bromodomain Inhibitor Review: Bromodomain and Extra-terminal Family Protein Inhibitors as a Potential New Therapy in Central Nervous System Tumors. Wadhwa E; Nicolaides T Cureus; 2016 May; 8(5):e620. PubMed ID: 27382528 [TBL] [Abstract][Full Text] [Related]
8. Use of epigenetic modulators as a powerful adjuvant for breast cancer therapies. Claude-Taupin A; Boyer-Guittaut M; Delage-Mourroux R; Hervouet E Methods Mol Biol; 2015; 1238():487-509. PubMed ID: 25421676 [TBL] [Abstract][Full Text] [Related]
10. Treatment of cardiovascular pathology with epigenetically active agents: Focus on natural and synthetic inhibitors of DNA methylation and histone deacetylation. Chistiakov DA; Orekhov AN; Bobryshev YV Int J Cardiol; 2017 Jan; 227():66-82. PubMed ID: 27852009 [TBL] [Abstract][Full Text] [Related]
11. Targeting the PI3K/AKT/mTOR signaling pathway in medulloblastoma. Dimitrova V; Arcaro A Curr Mol Med; 2015; 15(1):82-93. PubMed ID: 25601471 [TBL] [Abstract][Full Text] [Related]
12. Advances in epigenetic glioblastoma therapy. Lee DH; Ryu HW; Won HR; Kwon SH Oncotarget; 2017 Mar; 8(11):18577-18589. PubMed ID: 28099914 [TBL] [Abstract][Full Text] [Related]
14. Recent Advances in the Targeting of Epigenetic Regulators in B-Cell Non-Hodgkin Lymphoma. Ribeiro ML; Reyes-Garau D; Armengol M; Fernández-Serrano M; Roué G Front Genet; 2019; 10():986. PubMed ID: 31681423 [TBL] [Abstract][Full Text] [Related]
15. Medulloblastoma molecular dissection: the way toward targeted therapy. Remke M; Ramaswamy V; Taylor MD Curr Opin Oncol; 2013 Nov; 25(6):674-81. PubMed ID: 24076581 [TBL] [Abstract][Full Text] [Related]